Luisa Puche - Feb 13, 2024 Form 4 Insider Report for RENOVARO BIOSCIENCES INC. (RENB)

Role
Chief Financial Officer
Signature
/s/ Luisa Puche
Stock symbol
RENB
Transactions as of
Feb 13, 2024
Transactions value $
$0
Form type
4
Date filed
2/16/2024, 09:13 AM
Previous filing
Oct 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RENB Option to Purchase Common Stock Disposed to Issuer -60K -100% 0 Feb 13, 2024 Common Stock 60K $6.15 Direct F1, F2
transaction RENB Option to Purchase Common Stock Award +60K 60K Feb 13, 2024 Common Stock 60K $1.92 Direct F2
transaction RENB Option to Purchase Common Stock Disposed to Issuer -60K -100% 0 Feb 13, 2024 Common Stock 60K $8.58 Direct F2, F3
transaction RENB Option to Purchase Common Stock Award +60K 60K Feb 13, 2024 Common Stock 60K $1.92 Direct F2
transaction RENB Option to Purchase Common Stock Disposed to Issuer -75K -100% 0 Feb 13, 2024 Common Stock 75K $2.38 Direct F2, F4
transaction RENB Option to Purchase Common Stock Award +75K 75K Feb 13, 2024 Common Stock 75K $1.92 Direct F2
transaction RENB Option to Purchase Common Stock Disposed to Issuer -80K -100% 0 Feb 13, 2024 Common Stock 80K $2.15 Direct F2, F5
transaction RENB Option to Purchase Common Stock Award +80K 80K Feb 13, 2024 Common Stock 80K $1.92 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested in three equal installments on January 7, 2019, January 7, 2020 and January 7, 2021.
F2 The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.
F3 The option vested in three equal installments on October 26, 2021, October 26, 2022 and October 26, 2023.
F4 The option vested on January 22, 2023.
F5 One third of the option vested on October 18, 2023, the remainder of the option vests equally on October 18, 2024 and October 18, 2025.